You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 3,939,178


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,939,178
Title: Certain pyrano [3,4-b]indoles and thiopyrano[3,4-b]indoles
Abstract:Indole derivatives characterized by having a 1,3,4,9-tetrahydropyrano[3,4-b]indole or 1,3,4,9-tetrahydrothiopyrano[3,4-b]indole nucleus bearing a substituent in position 1, said substituent incorporating an acid, ester or amide function therein, are disclosed. The nucleus is further substituted at position 1 and may be optionally substituted at positions 3, 4, 5, 6, 7, 8, and 9. The derivatives are useful antiinflammatory, analgesic, antibacterial and antifungal agents and methods for their preparation and use are also disclosed.
Inventor(s): Demerson; Christopher A. (St. Laurent, CA), Humber; Leslie G. (Dollard des Ormeaux, CA), Dobson; Thomas A. (Dollard des Ormeaux, CA), Jirkovsky; Ivo L. (Montreal, CA)
Assignee: American Home Products Corporation (New York, NY)
Application Number:05/289,714
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

United States Patent 3,939,178: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 3,939,178, titled "Certain pyrano[3,4-b]indoles and thiopyrano[3,4-b]indoles," is a significant patent that discloses novel indole derivatives. This patent, issued on February 17, 1976, is crucial for understanding the chemical and pharmaceutical innovations of its time.

Background of the Invention

The patent relates to the synthesis and properties of pyrano[3,4-b]indoles and thiopyrano[3,4-b]indoles, which are indole derivatives. These compounds have been of interest due to their potential biological activities and therapeutic applications[1].

Scope of the Patent

The scope of the patent encompasses the preparation, structure, and properties of the specified indole derivatives. Here are the key aspects:

Chemical Structure

The patent describes the chemical structures of 1,3,4,9-tetrahydropyrano[3,4-b]indoles and 1,3,4,9-tetrahydrothiopyrano[3,4-b]indoles. These compounds are characterized by their fused ring systems, which include a pyrano or thiopyrano moiety attached to an indole nucleus[1].

Synthesis

The patent details various methods for synthesizing these compounds, including reactions involving acetic acid and other reagents. The synthesis processes are critical for understanding how these compounds can be produced on a laboratory or industrial scale[1].

Properties and Applications

The patent highlights the potential biological and therapeutic properties of these indole derivatives. While the patent does not specify exact applications, it implies that these compounds could be useful in pharmaceutical research due to their unique chemical structures.

Claims of the Patent

The claims of the patent are essential for defining the scope of protection granted to the inventors. Here are some key claims:

Independent Claims

  • Claim 1: This claim describes the general structure of 1,3,4,9-tetrahydropyrano[3,4-b]indoles and 1,3,4,9-tetrahydrothiopyrano[3,4-b]indoles, specifying the substituents and the fused ring system[1].

Dependent Claims

  • Subsequent claims provide more detailed descriptions of specific compounds within the general structure, including variations in substituents and reaction conditions[1].

Patent Landscape

Understanding the patent landscape surrounding US 3,939,178 involves examining related patents, prior art, and subsequent developments.

Prior Art

The patent cites earlier work related to indole derivatives, such as US Patent 3,843,681, which was issued on October 22, 1974. This prior art is crucial for understanding the evolutionary path of indole chemistry[1].

Related Patents

Other patents, such as European Patent EP0238226A1, also discuss similar indole derivatives, indicating a broader interest in these compounds across different jurisdictions[2].

Impact on Future Research

The issuance of US 3,939,178 influenced subsequent research in organic chemistry and pharmaceuticals. It contributed to the development of new synthetic methods and the exploration of biological activities of indole derivatives.

Legal Status

The patent has expired, as indicated by its legal status. This means that the protected inventions are now in the public domain, and anyone can use the disclosed information without infringing on the original patent rights[1].

Search and Analysis Tools

For professionals conducting patent searches related to this area, tools like the USPTO's Patent Public Search, Global Dossier, and Common Citation Document (CCD) are invaluable. These resources help in identifying prior art, related patents, and the global patent family of a specific application[4].

Conclusion

United States Patent 3,939,178 is a significant contribution to the field of organic chemistry and pharmaceutical research. Its scope and claims provide a detailed framework for understanding and synthesizing novel indole derivatives. The patent landscape surrounding this invention highlights the ongoing interest in indole chemistry and its potential therapeutic applications.

Key Takeaways

  • Chemical Structure: The patent describes 1,3,4,9-tetrahydropyrano[3,4-b]indoles and 1,3,4,9-tetrahydrothiopyrano[3,4-b]indoles.
  • Synthesis Methods: Detailed methods for synthesizing these compounds are provided.
  • Potential Applications: The compounds have potential biological and therapeutic properties.
  • Claims: The patent includes independent and dependent claims defining the scope of protection.
  • Patent Landscape: The patent is part of a broader landscape of indole chemistry research.
  • Legal Status: The patent has expired and is now in the public domain.

FAQs

What are the main compounds described in US 3,939,178?

The main compounds are 1,3,4,9-tetrahydropyrano[3,4-b]indoles and 1,3,4,9-tetrahydrothiopyrano[3,4-b]indoles.

How are these compounds synthesized?

The synthesis involves reactions with acetic acid and other reagents to form the fused ring systems.

What are the potential applications of these compounds?

They have potential biological and therapeutic properties, although specific applications are not detailed in the patent.

Is the patent still in force?

No, the patent has expired and is now in the public domain.

How can one conduct a patent search related to this area?

Tools like the USPTO's Patent Public Search, Global Dossier, and Common Citation Document (CCD) can be used to identify related patents and prior art.

Sources

  1. US3939178A - Certain pyrano [3,4-b]indoles and thiopyrano[3,4-b]indoles - Google Patents
  2. EP0238226A1 - Substituted 1,3,4,9 ... - Google Patents
  3. Patent Claims Research Dataset - USPTO
  4. Search for patents - USPTO - USPTO

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 3,939,178

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 3,939,178

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 198787 ⤷  Subscribe
Australia 4255472 ⤷  Subscribe
Australia 463079 ⤷  Subscribe
Belgium 784284 ⤷  Subscribe
Bulgaria 60660 ⤷  Subscribe
Canada 1006875 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.